Oncology MSL: Lead Scientific Exchange

Corcept Therapeutics; San Antonio (TX); On-site; USD 160,000 - 220,000; Full time

Job summary

Corcept Therapeutics in the United States seeks an Oncology Medical Science Liaison to cover the South Central Texas region. The MSL will engage with thought leaders, present scientific data, and support education on Corcept products in oncology.

The ideal candidate holds an advanced degree and has 1–3+ years of MSL experience in oncology, with strong communication and presentation skills. Travel is expected 50–70% plus collaboration across multiple oncology teams.

Qualifications

• 1–3+ years of MSL experience in oncology
• 2+ years of oncology experience
• Advanced degree in clinical or medical science is required

Responsibilities

• Engage in scientifically meaningful discussions with thought leaders and HCPs in gynecologic oncology and other cancers
• Support Corcept products via in-depth scientific presentations and education on request
• Respond to medical inquiries from HCPs with timely, accurate information
• Develop relationships with thought leaders, patient advocacy groups, and oncology associations
• Capture and communicate insights to inform Corcept decisions
• Attend medical conferences, advisory boards, and participate in ad boards
• Maintain territory plans and adapt based on internal/external changes
• Travel approximately 50-70% of the time

Skills

Oncology knowledge

Communication skills

PowerPoint/Word/Excel

CRM experience

Education

Advanced degree in clinical or medical science (PhD, MD, PharmD, MSN, PA, NP)

Job description

Corcept Therapeutics in the United States seeks an Oncology Medical Science Liaison to cover the South Central Texas region. The MSL will engage with thought leaders, present scientific data, and support education on Corcept products in oncology.

The ideal candidate holds an advanced degree and has 1–3+ years of MSL experience in oncology, with strong communication and presentation skills. Travel is expected 50–70% plus collaboration across multiple oncology teams.